Cargando…
Pathogenicity of two COQ7 mutations and responses to 2,4‐dihydroxybenzoate bypass treatment
Primary ubiquinone (co‐enzyme Q) deficiency results in a wide range of clinical features due to mitochondrial dysfunction. Here, we analyse and characterize two mutations in the ubiquinone biosynthetic gene COQ7. One mutation from the only previously identified patient (V141E), and one (L111P) from...
Autores principales: | Wang, Ying, Smith, Christopher, Parboosingh, Jillian S., Khan, Aneal, Innes, Micheil, Hekimi, Siegfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618687/ https://www.ncbi.nlm.nih.gov/pubmed/28409910 http://dx.doi.org/10.1111/jcmm.13154 |
Ejemplares similares
-
The CoQ biosynthetic di-iron carboxylate hydroxylase COQ7 is inhibited by in vivo metalation with manganese but remains functional by metalation with cobalt
por: Wang, Ying, et al.
Publicado: (2022) -
A novel COQ7 mutation causing primarily neuromuscular pathology and its treatment options
por: Wang, Ying, et al.
Publicado: (2022) -
Minimal mitochondrial respiration is required to prevent cell death by inhibition of mTOR signaling in CoQ-deficient cells
por: Wang, Ying, et al.
Publicado: (2021) -
Optimizing genotype quality metrics for individual exomes and cohort analysis
por: Gordon, Paul MK, et al.
Publicado: (2012) -
Novel Homozygous Variant in COQ7 in Siblings With Hereditary Motor Neuropathy
por: Smith, Ian C., et al.
Publicado: (2023)